Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2024-08-06 00:00:00 ET · period of report 2024-08-05 · accession 0000874015-24-000189 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-06 | 2024-08-05 | IONS | Geary Richard S | EVP, Chief Development Off | S - Sale | $48.00 | -2,430 | 85.5K | -3% | -$116.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-05 | S | D | 2,430 | $48.00 | 85,508 | D | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on April 8, 2024. |